OT

Ozlem Tureci

GG Ganymed Pharmaceuticals Gmbh: 10 patents #1 of 30Top 4%
JM Johannes Gutenberg-Universität Mainz: 4 patents #1 of 13Top 8%
BA Biontech Ag: 3 patents #1 of 18Top 6%
BG Biontech Cell & Gene Therapies Gmbh: 1 patents #1 of 4Top 25%
Overall (2018): #3,649 of 503,207Top 1%
13
Patents 2018

Issued Patents 2018

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
10137195 Therapy involving antibodies against Claudin 18.2 for treatment of cancer Ugur Sahin 2018-11-27
10125196 Monoclonal antibodies for treatment of cancer Ugur Sahin, Michael Koslowski 2018-11-13
10117918 Antigen-specific T cell receptors and T cell epitopes Ugur Sahin, Petra Simon, Tana Omokoko 2018-11-06
10106800 Modification of RNA, producing an increased transcript stability and translation efficiency Ugur Sahin, Silke Holtkamp, Sebastian Kreiter 2018-10-23
10093736 Agents for treatment of claudin expressing cancer diseases Ugur Sahin, Christiane Stadler, Julia Holland, Hayat Bähr-Mahmud, Tim Beissert +4 more 2018-10-09
10053512 Antibodies against claudin 18.2 useful in cancer diagnosis Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll 2018-08-21
10036753 Identification of surface-associated antigens for tumor diagnosis and therapy Ugur Sahin, Michael Koslowski, Gerd Helftenbein, Dirk Usener, Volker Schlüter 2018-07-31
10022444 Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Ugur Sahin, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch, Cornelia Adriana Maria Heinz +1 more 2018-07-17
10017564 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Dirk Usener, Stefan Fritz, Christoph Uherek, Gunda Brandenburg +3 more 2018-07-10
9932401 Antibodies specific for claudin 6 (CLDN6) Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +2 more 2018-04-03
9919036 Identification of tumor-associated antigens for diagnosis and therapy Ugur Sahin, Michael Koslowski, Dirk Usener 2018-03-20
9910043 Identification of tumor-associated cell surface antigens for diagnosis and therapy Ugur Sahin, Gerd Helftenbein, Volker Schlüter 2018-03-06
9902778 Cancer therapy using CLDN6 target-directed antibodies in vivo Ugur Sahin, Michael Koslowski, Korden Walter, Maria Kreuzberg, Sylvia Luxen 2018-02-27